Nucs AI is heading to Boston for ASTRO 2026.

Our CEO, Nijat Ahmadov, and our VP of Corporate Development & Strategic Initiatives, Lucas Buchheim-Jurisson, will be at the 68th ASTRO Annual Meeting from September 27 to 29.

This year's program is a big one for us. Radiopharmaceutical therapy has its own workshops, and artificial intelligence is on the panel agenda.

Nucs AI is the AI company built for theranostics and molecular imaging, which puts us right where radiopharmaceutical therapy and AI meet.

‍

Reach out to us through the "contact us" button above.

‍